MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/rmdopen-2025-005717

Медицинская библиотека · RMD open · 2025

Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients.

Currado Damiano, Trunfio Francesca, Saracino Francesca, Kun Lyubomyra, Marino Annalisa, Corberi Erika, Orlando Antonio, Lamberti Ludovica, Frascà Leonardo, Gatti Marta, Berardicurti Onorina, Vomero Marta, Liakouli Vasiliki, Giacomelli Roberto, Navarini Luca

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with psoriasis and characterised by heterogeneous clinical manifestations, including peripheral and axial arthritis, enthesitis and dactylitis. A subset of patients exhibits a 'difficult-to-treat' (D2T) phenotype, necessitating complex therapeutic strategies. Metabolic syndrome (MetS) is highly prevalent in PsA patients and has been implicated in increased disease activity.This study aimed to evaluate the impact of MetS on the development of D2T phenotype in PsA and its potential implications for disease management.

METHODS

A cross-sectional study was conducted on PsA patients recruited from the Rheumatology Clinic at Fondazione Policlinico Campus Bio-Medico of Rome. Patients fulfilling the Classification Criteria for Psoriatic Arthritis criteria were assessed for disease activity and the presence of MetS according to National Cholesterol Education Programme Adult Treatment Panel III criteria. D2T PsA was defined based on the Rheumatoid Arthritis European Alliance of Associations for Rheumatolog criteria revised for PsA by Perrotta et al. Statistical analyses, including logistic regression and path analysis, were performed to explore associations between MetS and D2T PsA.

RESULTS

Among 182 PsA patients, 42.94% met MetS criteria. The D2T subset (n=66) demonstrated a significantly higher prevalence of MetS (81.82% vs 29.37%, p<0.0001). Logistic regression revealed a strong association between MetS and D2T PsA (OR 7.56, 95% CI 2.53 to 22.56, p<0.0001), and path analysis confirmed MetS as an independent predictor of D2T phenotype.

CONCLUSIONS

MetS is strongly associated with a D2T phenotype in PsA, suggesting that metabolic comorbidities contribute to disease severity and treatment resistance. Addressing metabolic dysfunction may be crucial in optimising therapeutic outcomes in PsA management.

Для цитирования: Currado Damiano, Trunfio Francesca, Saracino Francesca, Kun Lyubomyra, Marino Annalisa, Corberi Erika, Orlando Antonio, Lamberti Ludovica, Frascà Leonardo, Gatti Marta, Berardicurti Onorina, Vomero Marta, Liakouli Vasiliki, Giacomelli Roberto, Navarini Luca. Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients.. RMD open. 2025. DOI: 10.1136/rmdopen-2025-005717.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.